184 related articles for article (PubMed ID: 20017368)
41. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study.
Gottlieb J; Schulz TF; Welte T; Fuehner T; Dierich M; Simon AR; Engelmann I
Transplantation; 2009 May; 87(10):1530-7. PubMed ID: 19461490
[TBL] [Abstract][Full Text] [Related]
42. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
Cabalka AK
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
[TBL] [Abstract][Full Text] [Related]
43. [Influenza and other viral respiratory infections in recruits during the epidemiologic season of 1991-1992 in Poland].
Białek J; Brydak L
Przegl Epidemiol; 1993; 47(3):269-74. PubMed ID: 8234845
[TBL] [Abstract][Full Text] [Related]
44. The Effect of Antiviral Therapy on the Incidence of Bacterial Aggravations and Administration of Systemic Antibiotics in Patients with Acute Respiratory Viral Infections and Influenza (Results of International Cohort Observational Study).
Fazylov VC; Sitnikov IG; Malyshev NA; Silina EV; Shevshenko SB; Eganyan GA; Korsantiya BM; Groppa LG
Antibiot Khimioter; 2016; 61(11-12):39-47. PubMed ID: 29558059
[TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab.
Reeve CA; Whitehall JS; Buettner PG; Norton R; Reeve DM; Francis F
J Paediatr Child Health; 2006 May; 42(5):253-8. PubMed ID: 16712554
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of amixine reactivity and efficacy for prophylaxis of acute respiratory tract infections].
Selkova EP; Tur'ianov MC; Pantiukhova TN; Nikitina GI; Semenenko TA
Antibiot Khimioter; 2001; 46(10):14-8. PubMed ID: 11881188
[TBL] [Abstract][Full Text] [Related]
47. [Prophylactic administration of impulsin to clinically healthy children. The effect on T and B lymphocytes in peripheral blood (author's transl)].
Wiedermannová D; Lokaj J; Wiedermann D
Cas Lek Cesk; 1979 Oct; 118(40-41):1249-51. PubMed ID: 527003
[No Abstract] [Full Text] [Related]
48. [Combination drugs in the therapy of acute respiratory viral infections: Evaluation of clinical and economic effectiveness].
Zaitsev AA; Klochkov OI
Ter Arkh; 2015; 87(11):51-55. PubMed ID: 26821417
[TBL] [Abstract][Full Text] [Related]
49. [About non-specific prophylaxis of infections typical for organized groups].
Valevskiĭ VV; Alekseev VV; Mar'in GG; Sobolev AA; Gruzdeva OA; Tsapkova NN; Tutel'ian AV; Poriadina GI; Salmina TA; Riazanova AIu; Sokolov MA; Sibilev DV
Voen Med Zh; 2012 Nov; 333(11):51-6. PubMed ID: 23301292
[TBL] [Abstract][Full Text] [Related]
50. [A trial of using bifidumbacterin for the prevention of acute respiratory viral infections in Moscow's preschool institutions].
Serzhenko SV; Filatov NN
Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):61-2. PubMed ID: 8079570
[No Abstract] [Full Text] [Related]
51. [Cycloferon in emergency prophylaxis of respiratory viral infections and influenza].
Romantsov MG; Sologub TV; Petrov AIu; Kovalenko AL
Klin Med (Mosk); 2011; 89(1):51-4. PubMed ID: 21516768
[TBL] [Abstract][Full Text] [Related]
52. [Efficiency of cycloferon application in often ill children in the period of raised seasonal morbidity of acute respiratory infections].
Lialikau S; Yarmak S; Bedin P
Georgian Med News; 2013 Jan; (214):37-42. PubMed ID: 23388533
[TBL] [Abstract][Full Text] [Related]
53. [Community-acquired pneumonia among the conscripts of Interior Forces in Russia: characteristics of the epidemic process].
Iaroslavtsev VV; Sabanin IuV; Kas'kov OV; Rybin VV; Rikhter VV; Zavolozhin VA
Voen Med Zh; 2011 Nov; 332(11):40-3. PubMed ID: 22329171
[TBL] [Abstract][Full Text] [Related]
54. [New generation of drugs for prevention of viral infections].
Ershov FI
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):100-3. PubMed ID: 17886382
[TBL] [Abstract][Full Text] [Related]
55. [Epidemiology and development of prophylaxis of acute respiratory diseases and pneumonias in servicemen in modern conditions].
Zhogolev SL; Ogarkov PI; Zhogolev KD; Udal'tsov OE; Shipitsin KS; Zharkov DA
Voen Med Zh; 2010 Oct; 331(10):46-53. PubMed ID: 21254584
[TBL] [Abstract][Full Text] [Related]
56. [The epidemiologic effectiveness of the nonspecific prophylaxis of acute respiratory infections in organized collectives].
Semenenko TA; Perepelkin VS; Vasil'eva VI; Grushko TP; Katkov AI
Zh Mikrobiol Epidemiol Immunobiol; 1988 Nov; (11):71-5. PubMed ID: 3218425
[No Abstract] [Full Text] [Related]
57. Treatment and prevention of acute respiratory virus infections in children with leukocytic interferon.
Arnaoudova V
Virologie; 1976; 27(2):83-8. PubMed ID: 973346
[TBL] [Abstract][Full Text] [Related]
58. [Outlooks for using the interferon inducers in the treatment and prevention of influenza and acute respiratory viral diseases].
Sysoeva GM; Masycheva VI; Danilenko ED
Vestn Ross Akad Med Nauk; 2004; (11):33-8. PubMed ID: 15651662
[TBL] [Abstract][Full Text] [Related]
59. Antiviral options for biodefense.
Byrd CM; Grosenbach DW; Hruby DE
Curr Opin Virol; 2013 Oct; 3(5):537-41. PubMed ID: 23773331
[TBL] [Abstract][Full Text] [Related]
60. Intervention strategies for emerging respiratory virus infections: policy and public health considerations.
Nguyen-Van-Tam JS; Sellwood C
Curr Opin Virol; 2013 Apr; 3(2):192-8. PubMed ID: 23477831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
